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Toxoplasma gondii is an obligate intracellular zoonotic 
protozoan parasite that causes toxoplasmosis in most 
mammals, including domestic animals, wild animals, and 
humans (Boothroyd, 2009; Dubey, 2010). The family Felidae, 
which includes domestic cats, is the definitive host of T. 
gondii. The parasite can easily spread infection through the 
accidental swallowing of food or water contaminated with 
oocysts. Accordingly, T. gondii is prevalent in most areas of the 
world (Montazeri et al., 2020). Toxoplasmosis in humans and 
domestic animals can cause congenital disease, miscarriages 
and stillbirths, leading to not only problems of animal hygiene 
and public health, but also economic losses to farmers (Stelzer 
et al., 2019). Yet, no effective vaccine or preventive drug has 
yet been developed. Recently, along with increased overlap 
of the living space between humans, domestic animals, and 
wild animals, the number of cases of toxoplasmosis has been 
increasing annually. In fact, in 2015, we reported that the 
number of T. gondii infected-wild animals is increasing in 
Japan (Bando et al., 2015). Furthermore, T. gondii has been 
ranked among the top five human pathogens that cause life 
impairment and economic losses in the United States (Batz et 
al., 2012). Therefore, to develop novel therapeutic methods or 
medicines against T. gondii, basic research on the interaction 
between T. gondii and its host is essential.
The host immune resistance responses to T. gondii rely on 
innate and adaptive immunity (Lee et al., 2015; Ma et al., 2014; 
MacMicking, 2012). Interferon-γ (IFN-γ), which is produced 
by CD4+ T cells and natural killer cells and stimulates cell-
autonomous responses in both immune and non-immune cells, 
is the most important molecule for anti-T. gondii responses 
(Suzuki et al., 1988). IFN-γ plays a role in the activation of 
the STAT1 transcription factor and induction of the expression 
of hundreds of genes (Platanias, 2005). Some studies have 
shown that IFN-γ-inducible GTPases mediate parasiticidal 
and parasitostatic responses in mice (Taylor et al., 2007; Zhao 
et al., 2009; Yamamoto et al., 2012), whereas other recent 
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Toxoplasma gondii is a zoonotic protozoan pathogen that causes toxoplasmosis, 
an infectious disease that affects most mammals, including domestic animals, wild 
animals, and humans. Toxoplasmosis in domestic animals causes miscarriages or 
stillbirths, resulting in economic losses and posing a challenge in animal husbandry. 
T. gondii is thus an important pathogen that causes serious animal and public health 
issues, yet there is still no vaccine or preventative medicine. Therefore, efforts to 
develop novel treatments for toxoplasmosis and to understand the interaction between 
the host immune response and the parasite in host cells are essential. We know that 
interferon-γ (IFN-γ)-induced tryptophan degradation by indole-2,3-dioxygenase 
(IDO1) plays an important role in the IFN-γ-induced anti-T. gondii response. 
However, little is known about T. gondii virulence mechanisms targeting IDO1. 
Therefore, we focused on the T. gondii effector TgGRA15 and analyzed its virulence 
function and mechanism to antagonize the IDO1-mediated anti-T. gondii response. In 
this study, we demonstrate that inducible nitric oxide synthase is a key host factor for 
TgGRA15-dependent disruption of the IDO1-dependent anti-T. gondii response.
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studies have reported that these GTPases may not play major 
roles in IFN-γ dependent anti-T. gondii responses in human 
cells (Ohshima et al., 2015; Fisch et al., 2019). We have 
shown that IFN-γ stimulates the expression of indoleamine 
2,3-dioxygenase (IDO) and has an essential role in the anti-
T. gondii responses of various human cell types (Bando et al., 
2018b). Thus, although IFN-γ has a critical role in the anti-T. 
gondii response of both humans and mice, the IFN-γ-inducible 
effector mechanisms may differ between these two species.
T. gondii secretes various effector molecules, called rhoptry 
proteins (ROPs) and dense granule proteins (GRAs), into 
host cells. These effectors are frequently used to promote 
parasite growth in host cells (Hakimi et al., 2017; Hunter 
and Sibley, 2012), and their virulence mechanisms, function, 
and significance have been extensively researched in mouse 
models (Behnke et al., 2011; Etheridge et al., 2014; Fentress et 
al., 2010; Reese et al., 2011; Rosowski et al., 2014; Rosowski 
and Saeij, 2012; Steinfeldt et al., 2010). The Toxoplasma 
effector TgGRA15, one of the dense granule proteins, is 
secreted into host cells to activate the host transcription 
factor NF-κB in mice (Gov et al., 2013; Jensen et al., 2011; 
Rosowski et al., 2011), although it should be noted that most 
virulence factors suppress the host immune responses (Olias 
et al., 2016; Gay et al., 2016). TgGRA15-deficient T. gondii 
has been shown to promote parasite proliferation in vivo in 
mice (Jensen et al., 2013; Rosowski et al., 2011), meaning that 
TgGRA15 can support host survival by preventing parasite 
growth. Thus, the significance of TgGRA15 as a virulence 
factor remains unclear. In this study, we introduce the virulent 
mechanism of TgGRA15 targeting the IDO1-dependent anti-T. 
gondii response in human cells.
TgGRA15 promotes T. gondii growth when 
co-cultured in the presence of IFN-γ
The function of TgGRA15 as a virulence factor is 
unclear; therefore, to explore it in human cells, we generated 
TgGRA15-deficient (TgGRA15-KO) T. gondii by using the 
CRISPR/Cas9 system. Then, we tested whether TgGRA15 has 
an important role in the suppression of host immune responses 
under human cell mono-culture conditions. However, we 
failed to find any advantageous effect of TgGRA15 on parasite 
growth in various human cell lines. When T. gondii infects 
its host, the parasite preferentially infects CD11b+ cells such 
as monocytes, and then the infected cells are carried by the 
bloodstream to various organs (Courret et al., 2006). Several 
kinds of co-culture models have been established to mimic 
complex cell-cell interactions by using human tissue or 
immune cell lines, one of which is the monocyte-hepatocyte 
co-culture model (Frenkel and Remington, 1980). Because 
one of the major symptoms of toxoplasmosis is hepatitis, 
we developed a T. gondii infection model using monocyte-
hepatocyte co-culture conditions. Human acute monocytic 
leukemia cell line THP-1 cells were infected with wild-type or 
TgGRA15-KO parasite, and then both the culture supernatant 
and infected THP-1 cells were seeded onto human hepatoma 
cell line Huh7 cells with or without IFN-γ. Interestingly, the 
parasite numbers under the TgGRA15-KO parasite-infected 
co-culture condition were significantly reduced compared with 
the wild-type parasite-infected co-culture condition. These 
data indicate that TgGRA15 has an advantageous effect on T. 
gondii growth under human cell co-culture conditions.
NLRP3-dependent IL-1β secretion from 
monocytes is essential for the pro-parasitic 
effect of TgGRA15 in hepatocytes
We next attempt to reveal the mechanisms of the pro-
parasitic effect of TgGRA15 under co-culture conditions. 
First, to test whether TgGRA15 has an effect on monocytes 
or hepatocytes, the culture supernatants were collected from 
wild-type and TgGRA15-KO T. gondii-infected THP-1 cells, 
and then both the parasites and THP-1 cells were removed by 
filtration. The filtered culture supernatants and newly prepared 
wild-type or TgGRA15-KO parasites were then added to 
Huh7 cells with IFN-γ. Then the number of parasites in the 
Huh7 cells was assessed. The presence of TgGRA15 in THP-1 
cells, but not Huh7 cells, led to a reduction in parasite number, 
suggesting that the presence of TgGRA15 in monocytes 
and their supernatant is essential for the pro-parasitic effect. 
Therefore, we next focused on the components of the 
supernatant from the parasite infected-THP-1 cell culture. 
Previous studies have reported that T. gondii infection induces 
proinflammatory cytokine IL-1β secretion from THP-1 cells in 
a TgGRA15-dependent manner (Gov et al., 2013). It has also 
been reported that IL-1β production in monocytes is dependent 
on Caspase-1 and inflammasome activation (Gov et al., 2013; 
Gov et al., 2017). Therefore, to test whether TgGRA15-
dependent Caspase-1 and inflammasome activation are 
important for IL-1β secretion from monocytes, we generated 
NLRP3-deficient (NLRP3-KO) or Caspase-1-deficient 
(CASP1-KO) THP-1 cells by using CRISPR/Cas9 systems, 
and then analyzed IL-1β secretion levels in the culture 
supernatant. We found that both NLRP3-KO- and CASP1-
KO-infected THP-1 cells showed significantly reduced IL-1β 
secretion. Then, we examined whether IL-1β secretion in THP-
1 cells is essential for suppressing the IFN-γ-dependent anti-T. 
gondii response under co-culture conditions. We found that the 
parasite number in both wild-type parasite-infected NLRP3-
KO and CASP1-KO THP-1 cells was significantly reduced 
compared with that of wild-type THP-1 cells. These results 
indicate that IL-1β secretion through Caspase-1 and NLRP3 
inflammasome activation in THP-1 cells has an important 
role in the TgGRA15-dependent suppression of the IFN-γ-
dependent anti-T. gondii response.
The IFN-γ-induced IDO1-dependent anti-T. 
gondii response is downregulated by TgGRA15 
in hepatocytes
We previously reported that IDO1-induced tryptophan 
degradation has an important role in the IFN-γ-dependent 
anti-T. gondii response in various human cell types including 
hepatocytes (Bando et al., 2018b; Bando et al., 2019) because 
tryptophan is an essential amino acid for parasite growth. 
In fact, we found that the IFN-γ-dependent reduction in 
parasite numbers in IDO1-deficient (IDO1-KO) Huh7 cells 
was abolished under TgGRA15-KO parasite-infected co-
culture conditions. Therefore, we examined whether IL-1β 
affects IDO1 expression in Huh7 cells. We found that IL-
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1β and IFN-γ co-stimulation severely inhibited IDO1 mRNA 
and protein levels in Huh7 cells. Then, to examine whether 
IL-1β-dependent impairment of the IFN-γ-dependent anti-T. 
gondii response was IDO1-dependent, we generated MyD88-
deficient (MyD88-KO)–– MyD88 is essential molecule for the 
IL-1 receptor signaling pathway (Adachi et al., 1998)––and 
IL1R1-deficient (IL1R1-KO) Huh7 cells by using CRISPR/
Cas9 systems. We found that the pro-parasitic effect of IL-
1β in IDO1-KO, MyD88-KO, and IL1R1-KO Huh7 cells was 
completely abolished. Then, we compared the protein levels of 
IDO1 under wild-type T. gondii- and TgGRA15-KO parasite-
infected and non-infected co-culture conditions. We found that 
the protein levels of IDO1 were significantly reduced under 
wild-type parasite-infected conditions compared with non-
infected conditions. Importantly, the protein levels of IDO1 
under TgGRA15-KO parasite-infected conditions recovered to 
the same levels as those seen under non-infected conditions. 
These results indicate that the TgGAR15-induced IL-1β-
dependent downregulation of IDO1 expression is important for 
the impairment of the IFN-γ-dependent anti-T. gondii response 
in hepatocytes.
iNOS is essential for TgGRA15-dependent 
inhibition of the IDO1-dependent anti-T. 
gondii response
Nitric oxide (NO) production is known to strongly 
downregulate IDO activity transcriptionally, translationally, 
and post-translationally (Thomas et al., 1994). In addition, 
inducible nitric oxide synthase (iNOS) has been shown to 
be an important factor for IFN-γ-mediated NO production 
(Nathan and Xie, 1994). Hence to explain the mechanism 
of the IL-1β-dependent IDO1 suppression, we focused on 
iNOS and NO-dependent downregulation of IDO1 activity 
in hepatocytes. First, we examined the expression level of 
iNOS mRNA in Huh7 cells. We found that IFN-γ and IL-1β 
co-stimulation enhanced the expression level of iNOS mRNA 
and strongly induced NO production in Huh7 cells. Then, 
to examine the role of iNOS, we generated iNOS-deficient 
(iNOS-KO) Huh7 cells by using the CRISPR/Cas9 system. We 
found that NO was not produced from iNOS-KO Huh7 cells 
upon IFN-γ and IL-1β co-stimulation and that IL-1β-dependent 
reduction of IDO1 protein levels did not occur in iNOS-KO 
Huh7 cells. Furthermore, the IL-1β-dependent pro-parasitic 
effect was completely abolished in the iNOS-KO Huh7 cells 
under mono-culture conditions, suggesting that IL-1β induces 
iNOS expression to inhibit the IDO1-dependent anti-T. gondii 
response. Then, we tested whether this mechanism occurs 
under co-culture conditions. We found that NO production 
and the reduction of IDO1 was not observed in iNOS-KO 
Huh7 cells co-cultured with wild-type parasite-infected wild-
type THP-1 cells. Moreover, the TgGRA15-dependent pro-
parasitic effect was abolished in iNOS-KO Huh7 cells under 
these co-culture conditions. Finally, we confirmed the GRA15-
dependent virulence mechanism in primary human cells. 
Taken together, our results indicate that iNOS is an essential 
host factor for the TgGRA15-dependent virulence mechanism 
under monocyte-hepatocyte co-culture conditions.
Conclusion
In summary, here we showed that IL-1β is produced from 
monocytes in a Toxoplasma effector TgGRA15- and host 
NLRP3 inflammasome-dependent manner. We further showed 
that iNOS has an essential role in the Toxoplasma TgGRA15-
dependent inhibition of the IDO1-induced anti-T gondii 
response in human cells (Bando et al., 2018a). Although 
immune responses in humans and domestic animals are not 
identical (Guzman and Montoya, 2018), the tryptophan-
degrading enzyme IDO and nitric oxide synthases NOS have 
been found in most mammalian species (Yao et al., 2011). 
Hence, the TgGRA15-dependent virulence mechanism may 
contribute to T. gondii infection in not only humans but also 
domestic animals. Studies to examine whether the TgGRA15-
dependent virulence mechanism has an important role in 
T. gondii infection of domestic animals, and to identify 
chemical compounds that block iNOS expression or NO 
production could contribute to the development of novel anti-
toxoplasmosis therapies for humans and domestic animals.
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